From molecule to market, orchestrated.
Humans and AI agents working side-by-side for Brand Manager, Regulatory Lead teams.
Compliance & Security
Recommended: WorkSwarm Private or On-Prem (air-gapped)
WorkSwarm operates in the most rigorous regulatory environment in our customer base. CDSCO under Drugs and Cosmetics Act for marketing materials and labeling, Schedule M for manufacturing records, GxP framework (GCP, GMP, GLP, GDP, GVP) where applicable, FDA 21 CFR Part 11 for electronic records, MoCRA for cosmetics in US scope, DPDP for patient data, IT Act for prescription handling. WorkSwarm provides per-record audit trails ready for FDA, CDSCO, or EU EMA inspection, and supports air-gapped on-prem deployment for the most sensitive workflows.
PHI stays inside the hospital. We come to it.
For Pharma operations, patient identifiers, clinical notes, and lab results stay inside the hospital network. Workswarm helps with reminders, follow up, and claim prep on de identified cohorts only.
Never leaves your side
- Patient names, MRNs, addresses, phone numbers
- Full clinical notes, lab results, imaging
- Insurance member IDs and claim details
- Doctor identifiers and prescription specifics
Crosses, encrypted
- Cohort sizes ("28 patients need follow up this week")
- Anonymous care pathway events
- Workswarm's draft messages and reminders
- Signed audit receipts
What Workswarm does
- Picks the right care pathway template
- Generates reminders and claim drafts in the hospital's voice
- Sends action back for staff to approve
- Never stores PHI. Stores workflow audit only.
Also relevant for Pharma
Law firm contracts and deals under attorney client privilege. Attorney client privilege preserved because privileged material never crosses the firm's perimeter. State bar and bar council confidentiality rules met. ISO 27001 controls match. GDPR processor obligations are minimized by design.
Workflows for this industry
2 live demos · 10 coming soon
Research Sprint
Quarterly research milestone closed across 8 contributors
Clinical Trial Coordination
Phase II site activation in 30 days vs 60 typical
Drug Launch Coordination
Multi-channel launch across 8 zones, regulatory compliant
Quarterly Research Sprint
Quarterly milestone closed across 8 contributors
Phase II Site Activation
Phase II site activation in 30 days vs 60 typical
Literature Review Sprint
480 papers screened, 96 included, evidence map shipped in 5 days
IRB Submission Pack
IRB submission accepted on first round, 0 deficiencies
Investigator Brochure Update
IB v6 published with safety updates, 0 site delays
Real World Evidence Collection
12K patient records ingested, dashboard live for medical affairs
Academic Publication
Paper submitted to NEJM, conflicts disclosed, reviewers tracked
Grant Proposal
NIH R01 submitted, budget validated, biosketches refreshed
Lab Inventory Audit
320 reagents counted, 18 expired flagged, 24 reordered
Join the Pharma & Life Sciences waitlist
Be first to run your brand manager workflows with WorkSwarm. Early access for Pharma & Life Sciences teams opens soon.
Join waitlist